Life-changing therapies

Innovative medicines pipeline
Macrocycle discovery platform
Collaborate with Polyphor

Innovative medicines pipeline

Antibiotics

Murepavadin (POL7080) – Pseudomonas infections

Phase 2

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Approval

OMPTA platform –  targeting Gram-negative resistant pathogens

Discovery (in vivo)

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Approval

Inhaled elastase inhibitor

POL6014 – Cystic Fibrosis

Phase 1

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Approval

CXCR4 antagonist

Balixafortide (POL6326) – for novel combination therapy of metastatic breast cancer

Phase 1

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Approval

Macrocycle discovery platform

New modalities to address challenging biological targets

Learn more

Collaborate with Polyphor

Pharma BD&L opportunities

Drug discovery collaborations